Mylan Inc (NASDAQ:MYL)

CAPS Rating: 3 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Recs

1
Player Avatar buckeyeshah (95.73) Submitted: 2/27/2010 8:15:19 PM : Outperform Start Price: $12.08 MYL Score: +173.31

Here is all you want to know. Take a look at CEO open market stock purchase in 2008-2009
95000 shares between $10 - $13

Mr. Robert J. Coury , 49
Chairman and Chief Exec. Officer
25-Feb-09 10,000 MYL Purchase at $12.97 per share.
(Cost of $129,700)
24-Feb-09 15,000 MYL Purchase at $12.90 per share.
(Cost of $193,500)
23-Feb-09 25,000 MYL Purchase at $12.86 per share.
(Cost of $321,500)
27-Jul-08 30,591 MYL Option Exercise at $0 per share.
27-Jul-08 12,107 MYL Disposition (Non Open Market) at $13.26 per share.
(Value of $160,538)
31-Mar-08 8,512 MYL Disposition (Non Open Market) at $11.60 per share.
(Value of $98,739)
18-Mar-08 25,575 MYL Option Exercise at $0 per share.
18-Mar-08 10,131 MYL Disposition (Non Open Market) at $11.18 per share.
(Value of $113,264)
7-Mar-08 20,000 MYL Purchase at $10.14 per share.
(Cost of $202,800)
6-Mar-08 10,000 MYL Purchase at $10.74 per share.
(Cost of $107,400)
5-Mar-08 15,000 MYL Purchase at $10.91 per share.
(Cost of $163,650)

Featured Broker Partners


Advertisement